$PLRX Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in PLIANT THERAPEUTICS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in PLIANT THERAPEUTICS, INC.. Get notifications about new insider transactions in PLIANT THERAPEUTICS, INC. for free.
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 22 2021 | PLRX | PLIANT THERAPEUTIC ... | Lefebvre Eric | Chief Medical Offic ... | Sell | S | 30.23 | 22 | 665 | 137,080 | 137.1 K to 137.1 K (-0.02 %) |
| Jun 22 2021 | PLRX | PLIANT THERAPEUTIC ... | Lefebvre Eric | Chief Medical Offic ... | Sell | S | 29.43 | 3,728 | 109,718 | 137,102 | 140.8 K to 137.1 K (-2.65 %) |
| Jun 22 2021 | PLRX | PLIANT THERAPEUTIC ... | Lefebvre Eric | Chief Medical Offic ... | Sell | S | 28.62 | 8,750 | 250,438 | 140,830 | 149.6 K to 140.8 K (-5.85 %) |
| May 28 2021 | PLRX | PLIANT THERAPEUTIC ... | Hull Hans | Chief Business Offi ... | Option Exercise | M | 2.08 | 4,500 | 9,360 | 12,979 | |
| May 28 2021 | PLRX | PLIANT THERAPEUTIC ... | Hull Hans | Chief Business Offi ... | Buy | M | 2.08 | 4,500 | 9,360 | 125,246 | 120.7 K to 125.2 K (+3.73 %) |
| Apr 15 2021 | PLRX | PLIANT THERAPEUTIC ... | Coulie Bernard | President and CEO | Option Exercise | M | 2.08 | 6,000 | 12,480 | 337,380 | |
| Apr 15 2021 | PLRX | PLIANT THERAPEUTIC ... | Coulie Bernard | President and CEO | Sell | S | 30.33 | 3,500 | 106,161 | 456,817 | 460.3 K to 456.8 K (-0.76 %) |
| Apr 15 2021 | PLRX | PLIANT THERAPEUTIC ... | Coulie Bernard | President and CEO | Buy | M | 2.08 | 6,000 | 12,480 | 54,840 | 48.8 K to 54.8 K (+12.29 %) |
| Mar 19 2021 | PLRX | PLIANT THERAPEUTIC ... | Lefebvre Eric | Chief Medical Offic ... | Sell | S | 39.78 | 1,135 | 45,150 | 149,580 | 150.7 K to 149.6 K (-0.75 %) |
| Mar 19 2021 | PLRX | PLIANT THERAPEUTIC ... | Lefebvre Eric | Chief Medical Offic ... | Sell | S | 39.38 | 11,365 | 447,528 | 150,715 | 162.1 K to 150.7 K (-7.01 %) |
| Mar 17 2021 | PLRX | PLIANT THERAPEUTIC ... | Coulie Bernard | President and CEO | Sell | S | 39.69 | 178 | 7,064 | 460,317 | 460.5 K to 460.3 K (-0.04 %) |
| Mar 17 2021 | PLRX | PLIANT THERAPEUTIC ... | Coulie Bernard | President and CEO | Sell | S | 38.75 | 2,000 | 77,501 | 460,495 | 462.5 K to 460.5 K (-0.43 %) |
| Mar 17 2021 | PLRX | PLIANT THERAPEUTIC ... | Coulie Bernard | President and CEO | Sell | S | 38.03 | 1,322 | 50,270 | 462,495 | 463.8 K to 462.5 K (-0.29 %) |
| Mar 05 2021 | PLRX | PLIANT THERAPEUTIC ... | Cummings Keith Lamont | Chief Financial Off ... | Option Exercise | M | 2.08 | 20,000 | 41,600 | 170,097 | |
| Mar 05 2021 | PLRX | PLIANT THERAPEUTIC ... | Cummings Keith Lamont | Chief Financial Off ... | Buy | M | 2.08 | 20,000 | 41,600 | 47,621 | 27.6 K to 47.6 K (+72.41 %) |
| Feb 17 2021 | PLRX | PLIANT THERAPEUTIC ... | Coulie Bernard | President and CEO | Sell | S | 34.07 | 200 | 6,814 | 463,817 | 464 K to 463.8 K (-0.04 %) |
| Feb 17 2021 | PLRX | PLIANT THERAPEUTIC ... | Coulie Bernard | President and CEO | Sell | S | 32.87 | 2,100 | 69,018 | 464,017 | 466.1 K to 464 K (-0.45 %) |
| Feb 17 2021 | PLRX | PLIANT THERAPEUTIC ... | Coulie Bernard | President and CEO | Sell | S | 32.10 | 1,200 | 38,520 | 466,117 | 467.3 K to 466.1 K (-0.26 %) |
| Jan 26 2021 | PLRX | PLIANT THERAPEUTIC ... | Howes Barbara | Chief Human Resourc ... | Option Exercise | A | 26.50 | 42,500 | 1,126,250 | 42,500 | |
| Jan 26 2021 | PLRX | PLIANT THERAPEUTIC ... | Coulie Bernard | President and CEO | Option Exercise | A | 26.50 | 250,000 | 6,625,000 | 250,000 | |
| Jan 26 2021 | PLRX | PLIANT THERAPEUTIC ... | Cummings Keith Lamont | Chief Financial Off ... | Option Exercise | A | 26.50 | 74,250 | 1,967,625 | 74,250 | |
| Jan 26 2021 | PLRX | PLIANT THERAPEUTIC ... | Lefebvre Eric | Chief Medical Offic ... | Option Exercise | A | 26.50 | 73,250 | 1,941,125 | 73,250 | |
| Jan 26 2021 | PLRX | PLIANT THERAPEUTIC ... | Hull Hans | Chief Business Offi ... | Option Exercise | A | 26.50 | 62,250 | 1,649,625 | 62,250 | |
| Jan 26 2021 | PLRX | PLIANT THERAPEUTIC ... | Ouimette Mike | General Counsel & C ... | Option Exercise | A | 26.50 | 15,520 | 411,280 | 15,520 | |
| Jan 15 2021 | PLRX | PLIANT THERAPEUTIC ... | Coulie Bernard | President and CEO | Sell | S | 27.21 | 630 | 17,145 | 467,317 | 467.9 K to 467.3 K (-0.13 %) |
| Jan 15 2021 | PLRX | PLIANT THERAPEUTIC ... | Coulie Bernard | President and CEO | Sell | S | 26.20 | 2,870 | 75,180 | 467,947 | 470.8 K to 467.9 K (-0.61 %) |
| Jan 13 2021 | PLRX | PLIANT THERAPEUTIC ... | PYOTT DAVID E I | Director | Option Exercise | A | 27.71 | 26,573 | 736,338 | 26,573 | |
| Jan 04 2021 | PLRX | PLIANT THERAPEUTIC ... | Hull Hans | Chief Business Offi ... | Option Exercise | M | 2.08 | 3,500 | 7,280 | 17,479 | |
| Jan 04 2021 | PLRX | PLIANT THERAPEUTIC ... | Hull Hans | Chief Business Offi ... | Buy | M | 2.08 | 3,500 | 7,280 | 120,746 | 117.2 K to 120.7 K (+2.99 %) |
| Dec 23 2020 | PLRX | PLIANT THERAPEUTIC ... | Cummings Keith Lamont | Chief Financial Off ... | Option Exercise | M | 2.08 | 4,500 | 9,360 | 190,097 | |
| Dec 23 2020 | PLRX | PLIANT THERAPEUTIC ... | Cummings Keith Lamont | Chief Financial Off ... | Buy | M | 2.08 | 4,500 | 9,360 | 27,621 | 23.1 K to 27.6 K (+19.46 %) |
| Dec 21 2020 | PLRX | PLIANT THERAPEUTIC ... | Lefebvre Eric | Chief Medical Offic ... | Sell | S | 26.98 | 5,712 | 154,110 | 162,080 | 167.8 K to 162.1 K (-3.40 %) |
| Dec 21 2020 | PLRX | PLIANT THERAPEUTIC ... | Lefebvre Eric | Chief Medical Offic ... | Sell | S | 26.17 | 6,788 | 177,642 | 167,792 | 174.6 K to 167.8 K (-3.89 %) |
| Dec 21 2020 | PLRX | PLIANT THERAPEUTIC ... | Lefebvre Eric | Chief Medical Offic ... | Sell | S | 26.98 | 5,712 | 154,110 | 162,080 | 167.8 K to 162.1 K (-3.40 %) |
| Dec 21 2020 | PLRX | PLIANT THERAPEUTIC ... | Lefebvre Eric | Chief Medical Offic ... | Sell | S | 26.17 | 6,788 | 177,642 | 167,792 | 174.6 K to 167.8 K (-3.89 %) |
| Dec 16 2020 | PLRX | PLIANT THERAPEUTIC ... | Coulie Bernard | President and CEO | Sell | S | 27.86 | 337 | 9,388 | 470,817 | 471.2 K to 470.8 K (-0.07 %) |
| Dec 16 2020 | PLRX | PLIANT THERAPEUTIC ... | Coulie Bernard | President and CEO | Sell | S | 27.32 | 3,163 | 86,402 | 471,154 | 474.3 K to 471.2 K (-0.67 %) |
| Dec 02 2020 | PLRX | PLIANT THERAPEUTIC ... | Cummings Keith Lamont | Chief Financial Off ... | Option Exercise | M | 6.22 | 7,143 | 44,429 | 35,698 | |
| Dec 02 2020 | PLRX | PLIANT THERAPEUTIC ... | Cummings Keith Lamont | Chief Financial Off ... | Option Exercise | M | 2.08 | 11,591 | 24,109 | 194,597 | |
| Dec 02 2020 | PLRX | PLIANT THERAPEUTIC ... | Cummings Keith Lamont | Chief Financial Off ... | Sell | S | 30.72 | 846 | 25,989 | 23,121 | 24 K to 23.1 K (-3.53 %) |
| Dec 02 2020 | PLRX | PLIANT THERAPEUTIC ... | Cummings Keith Lamont | Chief Financial Off ... | Sell | S | 30.21 | 14,901 | 450,159 | 24 | 14.9 K to 24 (-99.84 %) |
| Dec 02 2020 | PLRX | PLIANT THERAPEUTIC ... | Cummings Keith Lamont | Chief Financial Off ... | Sell | S | 29.07 | 1,848 | 53,721 | 38,868 | 40.7 K to 38.9 K (-4.54 %) |
| Dec 02 2020 | PLRX | PLIANT THERAPEUTIC ... | Cummings Keith Lamont | Chief Financial Off ... | Sell | S | 28.24 | 1,139 | 32,165 | 40,716 | 41.9 K to 40.7 K (-2.72 %) |
| Dec 02 2020 | PLRX | PLIANT THERAPEUTIC ... | Cummings Keith Lamont | Chief Financial Off ... | Buy | M | 6.22 | 7,143 | 44,429 | 41,855 | 34.7 K to 41.9 K (+20.58 %) |
| Dec 02 2020 | PLRX | PLIANT THERAPEUTIC ... | Cummings Keith Lamont | Chief Financial Off ... | Buy | M | 2.08 | 11,591 | 24,109 | 34,712 | 23.1 K to 34.7 K (+50.13 %) |
| Oct 13 2020 | PLRX | PLIANT THERAPEUTIC ... | Ouimette Mike | General Counsel | Option Exercise | A | 24.32 | 108,240 | 2,632,397 | 108,240 | |
| Jun 09 2020 | PLRX | PLIANT THERAPEUTIC ... | Hull Hans | Chief Business Offi ... | Option Exercise | C | 0.00 | 27,322 | 0 | 0 | |
| Jun 09 2020 | PLRX | PLIANT THERAPEUTIC ... | Hull Hans | Chief Business Offi ... | Option Exercise | C | 0.00 | 27,322 | 0 | 0 | |
| Jun 09 2020 | PLRX | PLIANT THERAPEUTIC ... | Hull Hans | Chief Business Offi ... | Option Exercise | C | 0.00 | 36,319 | 0 | 0 | |
| Jun 09 2020 | PLRX | PLIANT THERAPEUTIC ... | Hull Hans | Chief Business Offi ... | Option Exercise | C | 0.00 | 36,319 | 0 | 0 | |
| Jun 09 2020 | PLRX | PLIANT THERAPEUTIC ... | Hull Hans | Chief Business Offi ... | Option Exercise | A | 6.22 | 70,352 | 437,589 | 70,352 | |
| Jun 09 2020 | PLRX | PLIANT THERAPEUTIC ... | Hull Hans | Chief Business Offi ... | Option Exercise | A | 6.22 | 70,352 | 437,589 | 70,352 | |
| Jun 09 2020 | PLRX | PLIANT THERAPEUTIC ... | Hull Hans | Chief Business Offi ... | Option Exercise | A | 0.00 | 27,322 | 0 | 27,322 | |
| Jun 09 2020 | PLRX | PLIANT THERAPEUTIC ... | Hull Hans | Chief Business Offi ... | Option Exercise | A | 0.00 | 27,322 | 0 | 27,322 | |
| Jun 09 2020 | PLRX | PLIANT THERAPEUTIC ... | Hull Hans | Chief Business Offi ... | Buy | C | 0.00 | 3,821 | 0 | 3,821 | 0 to 3.8 K |
| Jun 09 2020 | PLRX | PLIANT THERAPEUTIC ... | Hull Hans | Chief Business Offi ... | Buy | C | 0.00 | 3,821 | 0 | 3,821 | 0 to 3.8 K |
| Jun 09 2020 | PLRX | PLIANT THERAPEUTIC ... | Hull Hans | Chief Business Offi ... | Buy | C | 0.00 | 5,079 | 0 | 117,246 | 112.2 K to 117.2 K (+4.53 %) |
| Jun 09 2020 | PLRX | PLIANT THERAPEUTIC ... | Hull Hans | Chief Business Offi ... | Buy | C | 0.00 | 5,079 | 0 | 117,246 | 112.2 K to 117.2 K (+4.53 %) |
| Jun 09 2020 | PLRX | PLIANT THERAPEUTIC ... | Huh Hoyoung | Director | Option Exercise | C | 0.00 | 1,000,000 | 0 | 0 | |
| Jun 09 2020 | PLRX | PLIANT THERAPEUTIC ... | Huh Hoyoung | Director | Option Exercise | C | 0.00 | 1,000,000 | 0 | 0 | |
| Jun 09 2020 | PLRX | PLIANT THERAPEUTIC ... | Huh Hoyoung | Director | Buy | C | 0.00 | 139,860 | 0 | 239,619 | 99.8 K to 239.6 K (+140.20 %) |
| Jun 09 2020 | PLRX | PLIANT THERAPEUTIC ... | Huh Hoyoung | Director | Buy | C | 0.00 | 139,860 | 0 | 239,619 | 99.8 K to 239.6 K (+140.20 %) |
| Jun 09 2020 | PLRX | PLIANT THERAPEUTIC ... | Cummings Keith Lamont | Chief Financial Off ... | Option Exercise | C | 0.00 | 27,322 | 0 | 0 | |
| Jun 09 2020 | PLRX | PLIANT THERAPEUTIC ... | Cummings Keith Lamont | Chief Financial Off ... | Option Exercise | C | 0.00 | 27,322 | 0 | 0 | |
| Jun 09 2020 | PLRX | PLIANT THERAPEUTIC ... | Cummings Keith Lamont | Chief Financial Off ... | Option Exercise | M | 2.08 | 19,300 | 40,144 | 206,188 | |
| Jun 09 2020 | PLRX | PLIANT THERAPEUTIC ... | Cummings Keith Lamont | Chief Financial Off ... | Option Exercise | M | 2.08 | 19,300 | 40,144 | 206,188 | |
| Jun 09 2020 | PLRX | PLIANT THERAPEUTIC ... | Cummings Keith Lamont | Chief Financial Off ... | Option Exercise | A | 6.22 | 42,841 | 266,471 | 42,841 | |
| Jun 09 2020 | PLRX | PLIANT THERAPEUTIC ... | Cummings Keith Lamont | Chief Financial Off ... | Option Exercise | A | 6.22 | 42,841 | 266,471 | 42,841 | |
| Jun 09 2020 | PLRX | PLIANT THERAPEUTIC ... | Cummings Keith Lamont | Chief Financial Off ... | Option Exercise | A | 0.00 | 27,322 | 0 | 27,322 | |
| Jun 09 2020 | PLRX | PLIANT THERAPEUTIC ... | Cummings Keith Lamont | Chief Financial Off ... | Option Exercise | A | 0.00 | 27,322 | 0 | 27,322 | |
| Jun 09 2020 | PLRX | PLIANT THERAPEUTIC ... | Cummings Keith Lamont | Chief Financial Off ... | Buy | C | 0.00 | 3,821 | 0 | 23,121 | 19.3 K to 23.1 K (+19.80 %) |
| Jun 09 2020 | PLRX | PLIANT THERAPEUTIC ... | Cummings Keith Lamont | Chief Financial Off ... | Buy | C | 0.00 | 3,821 | 0 | 23,121 | 19.3 K to 23.1 K (+19.80 %) |
| Jun 09 2020 | PLRX | PLIANT THERAPEUTIC ... | Cummings Keith Lamont | Chief Financial Off ... | Buy | M | 2.08 | 19,300 | 40,144 | 19,300 | 0 to 19.3 K |
| Jun 09 2020 | PLRX | PLIANT THERAPEUTIC ... | Cummings Keith Lamont | Chief Financial Off ... | Buy | M | 2.08 | 19,300 | 40,144 | 19,300 | 0 to 19.3 K |
| Jun 09 2020 | PLRX | PLIANT THERAPEUTIC ... | Howes Barbara | Chief Human Resourc ... | Option Exercise | C | 0.00 | 27,322 | 0 | 0 | |
| Jun 09 2020 | PLRX | PLIANT THERAPEUTIC ... | Howes Barbara | Chief Human Resourc ... | Option Exercise | C | 0.00 | 27,322 | 0 | 0 | |
| Jun 09 2020 | PLRX | PLIANT THERAPEUTIC ... | Howes Barbara | Chief Human Resourc ... | Option Exercise | A | 6.22 | 7,584 | 47,172 | 7,584 | |
| Jun 09 2020 | PLRX | PLIANT THERAPEUTIC ... | Howes Barbara | Chief Human Resourc ... | Option Exercise | A | 6.22 | 7,584 | 47,172 | 7,584 | |
| Jun 09 2020 | PLRX | PLIANT THERAPEUTIC ... | Howes Barbara | Chief Human Resourc ... | Option Exercise | A | 0.00 | 27,322 | 0 | 27,322 | |
| Jun 09 2020 | PLRX | PLIANT THERAPEUTIC ... | Howes Barbara | Chief Human Resourc ... | Option Exercise | A | 0.00 | 27,322 | 0 | 27,322 | |
| Jun 09 2020 | PLRX | PLIANT THERAPEUTIC ... | Howes Barbara | Chief Human Resourc ... | Buy | C | 0.00 | 3,821 | 0 | 24,799 | 21 K to 24.8 K (+18.21 %) |
| Jun 09 2020 | PLRX | PLIANT THERAPEUTIC ... | Howes Barbara | Chief Human Resourc ... | Buy | C | 0.00 | 3,821 | 0 | 24,799 | 21 K to 24.8 K (+18.21 %) |
| Jun 09 2020 | PLRX | PLIANT THERAPEUTIC ... | Third Rock Ventures III, L.P. | 10% Owner | Option Exercise | C | 0.00 | 15,250,000 | 0 | 0 | |
| Jun 09 2020 | PLRX | PLIANT THERAPEUTIC ... | Third Rock Ventures III, L.P. | 10% Owner | Option Exercise | C | 0.00 | 15,250,000 | 0 | 0 | |
| Jun 09 2020 | PLRX | PLIANT THERAPEUTIC ... | Third Rock Ventures III, L.P. | 10% Owner | Option Exercise | C | 0.00 | 39,750,000 | 0 | 0 | |
| Jun 09 2020 | PLRX | PLIANT THERAPEUTIC ... | Third Rock Ventures III, L.P. | 10% Owner | Option Exercise | C | 0.00 | 39,750,000 | 0 | 0 | |
| Jun 09 2020 | PLRX | PLIANT THERAPEUTIC ... | Third Rock Ventures III, L.P. | 10% Owner | Buy | C | 0.00 | 2,132,867 | 0 | 2,132,867 | 0 to 2.1 M |
| Jun 09 2020 | PLRX | PLIANT THERAPEUTIC ... | Third Rock Ventures III, L.P. | 10% Owner | Buy | C | 0.00 | 2,132,867 | 0 | 2,132,867 | 0 to 2.1 M |
| Jun 09 2020 | PLRX | PLIANT THERAPEUTIC ... | Third Rock Ventures III, L.P. | 10% Owner | Buy | C | 0.00 | 5,559,440 | 0 | 5,839,160 | 279.7 K to 5.8 M (+1,987.50 %) |
| Jun 09 2020 | PLRX | PLIANT THERAPEUTIC ... | Third Rock Ventures III, L.P. | 10% Owner | Buy | C | 0.00 | 5,559,440 | 0 | 5,839,160 | 279.7 K to 5.8 M (+1,987.50 %) |
| Jun 09 2020 | PLRX | PLIANT THERAPEUTIC ... | Exter Neil | Director | Option Exercise | A | 6.22 | 26,573 | 165,284 | 26,573 | |
| Jun 09 2020 | PLRX | PLIANT THERAPEUTIC ... | Exter Neil | Director | Option Exercise | A | 6.22 | 26,573 | 165,284 | 26,573 | |
| Jun 09 2020 | PLRX | PLIANT THERAPEUTIC ... | Coulie Bernard | President and CEO | Option Exercise | C | 0.00 | 181,594 | 0 | 0 | |
| Jun 09 2020 | PLRX | PLIANT THERAPEUTIC ... | Coulie Bernard | President and CEO | Option Exercise | C | 0.00 | 181,594 | 0 | 0 | |
| Jun 09 2020 | PLRX | PLIANT THERAPEUTIC ... | Coulie Bernard | President and CEO | Option Exercise | M | 2.08 | 48,227 | 100,312 | 343,380 | |
| Jun 09 2020 | PLRX | PLIANT THERAPEUTIC ... | Coulie Bernard | President and CEO | Option Exercise | M | 2.08 | 48,227 | 100,312 | 343,380 | |
| Jun 09 2020 | PLRX | PLIANT THERAPEUTIC ... | Coulie Bernard | President and CEO | Option Exercise | M | 6.22 | 613 | 3,813 | 376,723 | |
| Jun 09 2020 | PLRX | PLIANT THERAPEUTIC ... | Coulie Bernard | President and CEO | Option Exercise | M | 6.22 | 613 | 3,813 | 376,723 | |
| Jun 09 2020 | PLRX | PLIANT THERAPEUTIC ... | Coulie Bernard | President and CEO | Option Exercise | A | 6.22 | 377,336 | 2,347,030 | 377,336 | |
| Jun 09 2020 | PLRX | PLIANT THERAPEUTIC ... | Coulie Bernard | President and CEO | Option Exercise | A | 6.22 | 377,336 | 2,347,030 | 377,336 | |
| Jun 09 2020 | PLRX | PLIANT THERAPEUTIC ... | Coulie Bernard | President and CEO | Buy | C | 0.00 | 25,397 | 0 | 474,317 | 448.9 K to 474.3 K (+5.66 %) |
| Jun 09 2020 | PLRX | PLIANT THERAPEUTIC ... | Coulie Bernard | President and CEO | Buy | C | 0.00 | 25,397 | 0 | 474,317 | 448.9 K to 474.3 K (+5.66 %) |
| Jun 09 2020 | PLRX | PLIANT THERAPEUTIC ... | Coulie Bernard | President and CEO | Buy | M | 2.08 | 48,227 | 100,312 | 48,840 | 613 to 48.8 K (+7,867.37 %) |
| Jun 09 2020 | PLRX | PLIANT THERAPEUTIC ... | Coulie Bernard | President and CEO | Buy | M | 2.08 | 48,227 | 100,312 | 48,840 | 613 to 48.8 K (+7,867.37 %) |
| Jun 09 2020 | PLRX | PLIANT THERAPEUTIC ... | Coulie Bernard | President and CEO | Buy | M | 6.22 | 613 | 3,813 | 613 | 0 to 613 |
| Jun 09 2020 | PLRX | PLIANT THERAPEUTIC ... | Coulie Bernard | President and CEO | Buy | M | 6.22 | 613 | 3,813 | 613 | 0 to 613 |
| Jun 09 2020 | PLRX | PLIANT THERAPEUTIC ... | Redmile Group, LLC | 10% Owner | Option Exercise | C | 0.00 | 13,661,202 | 0 | 0 | |
| Jun 09 2020 | PLRX | PLIANT THERAPEUTIC ... | Redmile Group, LLC | 10% Owner | Buy | C | 0.00 | 1,910,657 | 0 | 1,910,657 | 0 to 1.9 M |
Page: 1